首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >LIGA20 a lyso derivative of ganglioside GM1 given orally after cortical thrombosis reduces infarct size and associated cognition deficit.
【2h】

LIGA20 a lyso derivative of ganglioside GM1 given orally after cortical thrombosis reduces infarct size and associated cognition deficit.

机译:LIGA20是神经节苷脂GM1的溶血衍生物在皮层血栓形成后口服可减少梗塞面积和相关的认知功能障碍。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A bilateral photochemically induced thrombotic lesion of rat sensorimotor cortex (approximately 3 mm in diameter and 25 mm3 in volume) is associated with a persistent cognition (learning and memory) deficit, which was evaluated with water maze tasks. The N-dichloroacetylsphingosine derivative of lysoGM1 (LIGA20) administered after the lesion either i.v. or per or reduces the infarct size by 30-40% and attenuates the associated cognition deficits, presumably by limiting the extent of damage of neurons at risk located in the surroundings of the infarcted core (i.e., area penumbra). The LIGA20 protection is dose and time dependent. Maximal protection is afforded by a single dose of LIGA20 of 34 mumol/kg i.v. 1 hr after lesion or by a dose of 270 mumol/kg per os when administered 1 hr and 24 hr after the lesion. The protective effect of LIGA20 can be observed when the drug is administered i.v. up to 6 hr after the lesion. The protective efficacy of the oral administration of LIGA20 is related to its physiochemical properties, which, unlike those of GM1, allow absorption from the gastrointestinal tract. LIGA20 given orally reaches the brain promptly and rapidly inserts into the neuronal membranes. Here, by an unknown molecular mechanism, LIGA20 selectively reduces the pathological amplification of Ca2+ signaling elicited by persistent stimulation of ionotropic glutamate receptors in the area penumbra.
机译:大鼠感觉运动皮层的双侧光化学诱导的血栓形成病变(直径约3 mm,体积约25 mm3)与持续的认知(学习和记忆)不足有关,可通过水迷宫任务对其进行评估。病变后静脉内施用lysoGM1的N-二氯乙酰基鞘氨醇衍生物(LIGA20)。或通过将梗塞面积减少30-40%并减轻相关的认知障碍,大概是通过限制位于梗塞核心(即半影区)周围处于危险中的神经元的损伤程度。 LIGA20保护取决于剂量和时间。 LIGA20单次剂量为34 mumol / kg静脉注射可提供最大的保护。病变后1小时或病变后1小时和24小时给药,剂量为270μmol/ kg / os。当静脉内给药时,可以观察到LIGA20的保护作用。病变后长达6小时。口服LIGA20的保护功效与其理化性质有关,与GM1的理化性质不同,它允许从胃肠道吸收。口服LIGA20迅速到达大脑,并迅速插入神经元膜。在这里,由于未知的分子机制,LIGA20选择性地减少了对半影区离子型谷氨酸受体的持续刺激而引起的Ca2 +信号的病理放大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号